Abstract
Aim: To assess patient perception toward oral chemotherapy for solid tumors, the Italian Association of Medical Oncology performed a large multi-institutional national survey. Methods: A 17-item anonymous questionnaire including 7 general and 10 investigational questions with free-text, single-choice, or multiple-choice answers was administered. Analysis of response distribution according to predefined factors was described by summary measures and conducted by χ2 test and other nonparametric tests. Results: From January to June 2010, 581 patients completed the questionnaire; data of 404 patients constituted the final study sample. Three groups could be distinguished according to treatment: IV chemotherapy (IV group, n = 313), oral chemotherapy (oral group, n = 48), or combined therapy (combined group, n = 43). Thirty-one (72%) patients in the combined group and 187 (60%) in the IV group expressed preference for oral therapy (p = 0.028). Limitations in family and work commitment were more frequently perceived by patients on IV than oral chemotherapy (147 (47%) vs 14 (29%) patients, p
Original language | English |
---|---|
Pages (from-to) | 108-113 |
Number of pages | 6 |
Journal | Tumori |
Volume | 102 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 1 2016 |
Keywords
- IV chemotherapy
- Oral chemotherapy
- Patient perspective
- Questionnaire
- Treatment
ASJC Scopus subject areas
- Cancer Research
- Oncology